A Giant Hepatic Hemangioma Complicated by Kasabach-Merritt Syndrome: Findings of Tc-99m RBC Scintigraphy and SPECT Including a Total Body Blood Pool Imaging Study.
- Author:
Myung Hee SOHN
1
;
Hwan Jeong JEONG
;
Seok Tae LIM
;
Dong Wook KIM
;
Chang Yeol YIM
Author Information
1. Department of Nuclear, Chonbuk National University Medical School, Jeonju, Jeonbuk, Korea. mhsohn@chonbuk.ac.kr
- Publication Type:Case Report
- Keywords:
Tc-99m RBC scintigraphy;
Kasabach-Merritt syndrome;
giant hemangioma;
thrombocytopenia;
coagulopathy
- MeSH:
Adult;
Anemia, Hemolytic;
Disseminated Intravascular Coagulation;
Hemangioma;
Humans;
Kasabach-Merritt Syndrome;
Mass Screening;
Thrombocytopenia;
Tomography, Emission-Computed, Single-Photon
- From:Nuclear Medicine and Molecular Imaging
2009;43(1):83-86
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Kasabach-Merritt syndrome (KMS) consists of thrombocytopenia, microangiopathic hemolytic anemia, and localized consumption coagulopathy that develops within vascular hemangioma. This syndrome may also be associated with occult hemangiomas located at various sites. Tc-99m RBC scintigraphy and SPECT have proven to be reliable for confirming or excluding hemangioma. Total body blood pool imaging study during the scintigraphy also provides a means of screening for occult lesions. The authors report the case of a 29-year-old man who presented with a giant hepatic hemangioma complicated by KMS, and underwent Tc-99m RBC scintigraphy and SPECT including a total body blood pool imaging study.
